PZU reported FY 2025 net profit of PLN 14.0 billion, with profit attributable to equity holders of PLN 6.7 billion and basic and diluted EPS of PLN 7.76. Operating profit was PLN 17.8 billion and profit before tax was PLN 17.8 billion. Insurance revenue totaled PLN 30.9 billion, with an insurance service result of PLN 4.8 billion (insurance service result before reinsurance: PLN 5.9 billion; net income/expenses from reinsurance contracts held: PLN -1.1 billion). Net cash flows from operating activities were PLN 10.5 billion, and cash and cash equivalents ended the year at PLN 16.2 billion; total assets were PLN 535.5 billion and total equity was PLN 72.7 billion. Key updates in the period included PZU Zdrowie’s acquisition of 100% of Humana Medica Omeda sp. z o.o. on 28 November 2025 for a purchase price of PLN 30 million, resulting in PLN 30 million of goodwill, with the business consolidated from the acquisition date. The group also reported changes in the consolidation scope of mutual funds during 2025, including the consolidation of PZU FIZ Forte Absolutnej Stopy Zwrotu (effective 28 January 2025), PZU FIZ Corporate Bonds (effective 1 April 2025) and PZU FIZ Private Debt (effective 25 September 2025), and the exclusion of certain funds from consolidation, including inPZU Polskie Obligacje Skarbowe (as of 1 February 2025) and inPZU Bitcoin (effective 31 December 2025).

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PZU - Powszechny Zaklad Ubezpieczen SA published the original content used to generate this news brief on March 02, 2026, and is solely responsible for the information contained therein.